Dr Reddy’s launches Sputnik V in India
Pharma major Dr Reddy’s Laboratories Ltd has launched Russia's Covid-19 vaccine, Sputnik V, in the domestic market, making it the third Covid-19 vaccine available in the country.
"As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad today," the company said.
Further consignments of imported doses are expected over the upcoming months. Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing partners, Business Line reported.
The imported doses of the vaccine are presently priced at an MRP of ₹948 excluding 5 per cent GST per dose, with the possibility of a lower price point when local supply begins.
Dr Reddy’s, a partner of Russian Director Investment Fund to be the brand custodian of Sputnik in India, had received 1.5 lakh doses of Sputnik V from Russia on May 1. The company received regulatory clearance from the Central Drug Laboratory, Kasauli, on May 13 to launch the vaccine in India.